Review/Cancer imagingSoft-tissue sarcoma in adults: Imaging appearances, pitfalls and diagnostic algorithms
Introduction
Sarcomas are rare malignant mesenchymal tumors divided into bone sarcomas, visceral sarcomas, and soft-tissue sarcomas (STS) [1]. Regarding STS, their rarity, ubiquity, and the diversity of their initial clinical and radiological presentations make them challenging to diagnose. Hence, 32 to 70% of patients with STS are not treated in agreement with international guidelines [2]. Yet, correctly orienting patients with a suspicion of STS towards sarcoma reference centers is crucial for their appropriate diagnostic and therapeutic management and to maximize the chance of favourable outcomes. Indeed, Blay et al. have shown in two large cohorts of 12,528 and 35,784 patients that patients managed inside sarcoma reference centers and with the expertise of multidisciplinary tumor board (MDTB) had significantly better compliance to clinical practice guidelines, better quality of the initial surgery with less reoperations, and lower rates of local and metastatic relapses compared to other patients [3,4]. In parallel, the organizations of care for patients with STS, such as the sarcoma network (NETSARC+) in France, have enabled active and collaborative clinical researches and data sharing and, consequently, a considerable amount of knowledge in the epidemiology, treatment, biology, and imaging of STS. The last guidelines published in 2021 by the European Society of Medical Oncology summarize the practical aspects of this knowledge for clinicians but with a limited overview of the improvements of imaging [5].
The purpose of this review was to summarize the current state of good practices for the imaging of patients with STS with an emphasis of the pivotal role of radiologists in the patients’ diagnostic management.
Section snippets
Epidemiology and presentation of STS
STS accounts for 1% of all adult malignancies, with 11 lineages and more than 80 different histologic and molecular subtypes [1,6,7]. Annual records have shown a progressive increase in the incidence of STS over the last decade with 13,100 new patients in the USA in 2020 compared to 11,280 in 2012 [7,8]. The incidence of STS grows with age, with a median age of approximately 60 years [9]. However, some STSs are more frequent in young patients, such as rhabdomyosarcoma and alveolar soft-part
First-line imaging: ultrasonography and conventional radiographs
The initial assessment of soft-tissue lumps usually begins with ultrasonography. Conventional radiography remains suggested by the American College of Radiology Appropriateness Committee, even for superficial masses, to look for the mineralization and bone erosion [42,43]. Conventional radiography can also help orienting towards primary bone origin with secondary extension to soft tissue. According to the European Society for musculoskeletal Radiology [44], ultrasonography should: (i), confirm
Local staging
Once the diagnosis of STS is proven and its grade estimated on biopsy, the local staging relies on MRI. The aim is to help the MDTB of the sarcoma reference centers select the best therapeutic approach. Thus, in addition to tumor size and depth, it is crucial to evaluate the operability by the surgeon, and to identify features associated with a higher grade than the ‘biopsy-grade’, as neoadjuvant treatments may be subsequently indicated.
Conclusion
Imaging has a central place in each phase of the management of STS patients, and both non-specialized and specialized radiologists can have a strong impact in the appropriate management of STS patients [3,4]. Indeed, during the diagnostic interval, knowing when continuing the radiological investigations, how to perform a good quality MRI able to provide the relevant information, and when addressing the patients rapidly to a sarcoma reference center can strongly impact the patients’ quality of
Human rights
The authors declare that the work described has been performed in accordance with the Declaration of Helsinki of the World Medical Association revised in 2013 for experiments involving humans.
Informed consent and patient details
The authors declare that this report does not contain any personal information that could lead to the identification of the patients.
Author contributions
All authors attest that they meet the current International Committee of Medical Journal Editors (ICMJE) criteria for Authorship.
CRediT authorship contribution statement
Amandine Crombé: Conceptualization, Methodology, Project administration, Supervision, Writing – original draft, Validation, Writing – review & editing, Resources. Michèle Kind: Conceptualization, Methodology, Writing – original draft, Validation, Writing – review & editing, Resources. David Fadli: Visualization, Writing – original draft, Validation, Writing – review & editing. Marco Miceli: Resources, Validation, Writing – review & editing. Pierre-Antoine Linck: Resources, Visualization,
Declaration of Competing Interest
The authors declare that they have no competing interest in relation with this article.
Funding
This article did not receive specific funding.
References (105)
- et al.
Improved survival using specialized multidisciplinary board in sarcoma patients
Ann Oncol
(2017) - et al.
Surgery in reference centers improves survival of sarcoma patients: a nationwide study
Ann Oncol
(2019) - et al.
Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS clinical practice guidelines for diagnosis, treatment and follow-up
Ann Oncol
(2021) - et al.
Soft tissue sarcoma after treatment for breast cancer: a Swedish population-based study
Eur J Cancer
(1998) - et al.
Soft tissue sarcoma in France in 2015: epidemiology, classification and organization of clinical care
J Visc Surg
(2015) Molecular biology of soft-tissue sarcomas
Bull Cancer
(2010)- et al.
Liposarcoma: multimodality management and future targeted therapies
Surg Oncol Clin N Am
(2016) - et al.
Development and external validation of two nomograms to predict overall survival and occurrence of distant metastases in adults after surgical resection of localised soft-tissue sarcomas of the extremities: a retrospective analysis
Lancet Oncol
(2016) - et al.
Role of perioperative chemotherapy in soft-tissue sarcomas: it's time to end a never-ending story
Eur J Cancer
(2018) - et al.
Neo)adjuvant treatment in localised soft tissue sarcoma: the unsolved affair
Eur J Cancer
(2017)
Homogeneous myxoid liposarcomas mimicking cysts on MRI: a challenging diagnosis
Eur J Radiol
Correlation between radiological assessment and histopathological diagnosis in retroperitoneal tumors: analysis of 291 consecutive patients at a tertiary reference sarcoma center
Eur J Surg Oncol
Diagnosis strategy of adipocytic soft-tissue tumors in adults: a consensus from European experts
Eur J Surg Oncol
Quantitative signal intensity ratios to distinguish between subfascial lipoma and atypical lipomatous tumor/well-differentiated liposarcoma using short-tau inversion recovery (STIR) MRI
Diagn Interv Imaging
Soft tissue sarcomas or intramuscular haematomas?
Eur J Radiol
Van der Graaf W. The sarcoma diagnostic interval: a systematic review on length, contributing factors and patient outcomes
ESMO Open
Natural speed of growth of untreated soft-tissue sarcomas: a dimension-based imaging analysis
Eur J Radiol
Primary retroperitoneal soft tissue sarcoma: imaging appearances, pitfalls and diagnostic algorithm
Eur J Surg Oncol
Bone invasion in soft tissue sarcomas of the extremities: an underappreciated prognostic factor
Surg Oncol
Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial
Lancet Oncol
MRI features as prognostic factors in myxofibrosarcoma: proposal of MRI grading system
Acad Radiol
Perfusion MR imaging at 3-Tesla: can it predict tumor grade and histologic necrosis rate of musculoskeletal sarcoma?
Diagn Interv Imaging
Early detection of multiple bone and extra-skeletal metastases by body magnetic resonance imaging after treatment of myxoid/round-cell liposarcoma
Eur J Surg Oncol
WHO classification of tumours of soft tissue and bone
Management of soft tissue sarcomas in extremities: variation in treatment recommendations and surveillance according to specialty and continent
Ann Surg Oncol
Soft-tissue sarcomas in adults
N Engl J Med
Cancer statistics, 2020
CA Cancer J Clin
Cancer statistics, 2012
CA Cancer J Clin
Incidence of sarcoma histotypes and molecular subtypes in a prospective epidemiological study with central pathology review and molecular testing
PLoS One
Incidence of soft tissue sarcoma and beyond: a population-based prospective study in 3 European regions
Cancer
Increased risk of soft tissue sarcoma after radiotherapy in women with breast carcinoma
Cancer
Incidence of bone and soft tissue sarcoma after radiotherapy: a cohort study of 295,712 Finnish cancer patients
Int J Cancer
Sarcomas associated with genetic cancer predisposition syndromes: a review
Oncologist
Oncodiagnosis panel: 2007: multidisciplinary management of soft-tissue sarcoma
Radiographics
Soft-tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system
Int J Cancer
The adequacy of core biopsy in the assessment of smooth muscle neoplasms of soft tissues: implications for treatment and prognosis
Am J Surg Pathol
The role of core needle biopsy in the diagnosis of suspected soft tissue tumours
J Surg Oncol
Accuracy of biopsy techniques for limb and limb girdle soft tissue tumors
Ann Surg Oncol
Soft-tissue sarcomas: assessment of MRI features correlating with histologic grade and patient outcome
Radiology
Grading of soft tissue sarcomas: review and update
Arch Pathol Lab Med
Prognostic factors in adult patients with locally controlled soft tissue sarcoma. a study of 546 patients from the French federation of cancer centers sarcoma group
J Clin Oncol
Comparative study of the national cancer institute and French federation of cancer centers sarcoma group grading systems in a population of 410 adult patients with soft tissue sarcoma
J Clin Oncol
Predictive value of grade for metastasis development in the main histologic types of adult soft tissue sarcomas: a study of 1240 patients from the French federation of cancer centers sarcoma group
Cancer
Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities
J Clin Oncol
Myxoid/round cell and pleomorphic liposarcomas
Cancer
Overall and net survival of patients with sarcoma between 2005 and 2010: results from the French network of cancer registries (FRANCIM)
Cancer
Soft-tissue sarcoma in adults: an update on the current state of histiotype-specific management in an era of personalized medicine
CA Cancer J Clin
Targetable alterations in adult patients with soft-tissue sarcomas: insights for personalized therapy
JAMA Oncol
Soft tissue sarcomas with complex genomic profiles
Virchows Arch
Validated prediction of clinical outcome in sarcomas and multiple types of cancer on the basis of a gene expression signature related to genome complexity
Nat Med
Cited by (10)
Radiomics and artificial intelligence for soft-tissue sarcomas: Current status and perspectives
2023, Diagnostic and Interventional ImagingNodular fasciitis: PET/CT and MR imaging features
2023, Diagnostic and Interventional ImagingImaging presentation of extraskeletal osteosarcomas on CT and MRI and correlation with patients outcome: A two-center retrospective study of 54 patients
2023, Diagnostic and Interventional ImagingThe role of the radiologist in the management of soft-tissue masses: With great power comes great responsibility
2023, Diagnostic and Interventional ImagingImaging Features of Alveolar Soft Part Sarcoma: Single Institution Experience and Literature Review
2023, Clinics and PracticeCalculating Tumor Volume Using Three-Dimensional Models in Preoperative Soft-Tissue Sarcoma Surgical Planning: Does Size Matter?
2023, Journal of Clinical Medicine